• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,202.32 211.10
( 0.27%)
Global Indices
Nasdaq
51,867.48 179.64
(0.35%)
Dow Jones
7,378.60 -7.86
(-0.11%)
Hang Seng
69,343.30 -445.08
(-0.64%)
Nikkei 225
10,453.87 25.02
(0.24%)
Forex
USD-INR
94.53 0.21
(0.22%)
EUR-INR
108.18 0.03
(0.03%)
GBP-INR
125.09 0.39
(0.31%)
JPY-INR
0.58 0.00
(0.06%)

EQUITY - MARKET SCREENER

Aarti Pharmalabs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543748
INE0LRU01027
218.6629199
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AARTIPHARM
36.13
6442.59
EPS(TTM)
Face Value()
Div & Yield %
19.67
5
0.49
 

ambuja cements ltd
Ashok Leyland consolidated net profit rises 14.21% in the March 2026 quarter
May 28,2026
Net profit of Ashok Leyland rose 14.21% to Rs 1290.70 crore in the quarter ended March 2026 as against Rs 1130.09 crore during the previous quarter ended March 2025. Sales rose 17.09% to Rs 17138.90 crore in the quarter ended March 2026 as against Rs 14636.95 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.72% to Rs 3471.03 crore in the year ended March 2026 as against Rs 3106.80 crore during the previous year ended March 2025. Sales rose 16.00% to Rs 56076.03 crore in the year ended March 2026 as against Rs 48341.76 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales17138.9014636.95 17 56076.0348341.76 16
OPM %19.3020.43 -19.1619.05 -
PBDT2273.072071.27 10 6676.795667.58 18
PBT1959.061731.47 13 5539.234580.93 21
NP1290.701130.09 14 3471.033106.80 12